Vulnerability Description
The HoYoVerse (formerly miHoYo) Genshin Impact mhyprot2.sys 1.0.0.0 anti-cheat driver does not adequately restrict unprivileged function calls, allowing local, unprivileged users to execute arbitrary code with SYSTEM privileges on Microsoft Windows systems. The mhyprot2.sys driver must first be installed by a user with administrative privileges.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Hoyoverse | Mhyprot2 | 1.0.0.0 |
Related Weaknesses (CWE)
References
- https://github.com/kagurazakasanae/Mhyprot2DrvControlThird Party Advisory
- https://github.com/kkent030315/evil-mhyprot-cliThird Party Advisory
- https://web.archive.org/web/20211204031301/https://www.godeye.club/2021/05/20/00ExploitThird Party Advisory
- https://www.trendmicro.com/en_us/research/22/h/ransomware-actor-abuses-genshin-iExploitThird Party Advisory
- https://www.vice.com/en/article/y3p35w/hackers-are-using-anti-cheat-in-genshin-iExploitPress/Media CoverageThird Party Advisory
- https://github.com/kagurazakasanae/Mhyprot2DrvControlThird Party Advisory
- https://github.com/kkent030315/evil-mhyprot-cliThird Party Advisory
- https://web.archive.org/web/20211204031301/https://www.godeye.club/2021/05/20/00ExploitThird Party Advisory
- https://www.trendmicro.com/en_us/research/22/h/ransomware-actor-abuses-genshin-iExploitThird Party Advisory
- https://www.vice.com/en/article/y3p35w/hackers-are-using-anti-cheat-in-genshin-iExploitPress/Media CoverageThird Party Advisory
FAQ
What is CVE-2020-36603?
CVE-2020-36603 is a vulnerability with a CVSS score of 6.5 (MEDIUM). The HoYoVerse (formerly miHoYo) Genshin Impact mhyprot2.sys 1.0.0.0 anti-cheat driver does not adequately restrict unprivileged function calls, allowing local, unprivileged users to execute arbitrary ...
How severe is CVE-2020-36603?
CVE-2020-36603 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-36603?
Check the references section above for vendor advisories and patch information. Affected products include: Hoyoverse Mhyprot2.